Related Experiment Video
Updated: May 31, 2026
08:20
Hippocampal Neuronal Cultures to Detect and Study New Pathogenic Antibodies Involved in Autoimmune Encephalitis
Published on: June 2, 2022
Noncirrhotic hyperammonaemic encephalopathy
1Department of Internal Medicine A and Rabin Medical Center, Beilinson Hospital, Petah Tiqwa, Israel.
Summary
Adult hyperammonaemia often indicates severe liver disease, but noncirrhotic causes exist. Early diagnosis of hyperammonaemic encephalopathy, even with normal liver function, is crucial for timely, life-saving treatment.
Area of Science:
- Hepatology
- Neurology
- Internal Medicine
Background:
- Hyperammonaemia in adults is predominantly linked to severe liver disease (90% of cases).
- A significant minority of cases present with noncirrhotic causes, necessitating broader diagnostic considerations.
- Encephalopathy of unknown origin requires serum ammonia level assessment, irrespective of apparent liver function.
Purpose of the Study:
- To review the physiology, aetiology, and mechanisms of noncirrhotic hyperammonaemic encephalopathy.
- To discuss current treatment modalities for this condition.
- To enhance clinician awareness for earlier diagnosis and intervention.
Main Methods:
- Literature review focusing on hyperammonaemia and encephalopathy.
- Analysis of physiological and etiological factors.
- Synthesis of treatment strategies.
Main Results:
- Noncirrhotic causes of hyperammonaemia are critical to consider in encephalopathy.
- Serum ammonia measurement is essential in undiagnosed encephalopathy.
- Awareness can lead to prompt, life-saving interventions.
Conclusions:
- Clinician awareness of noncirrhotic hyperammonaemic encephalopathy is vital.
- Early diagnosis and treatment can significantly improve patient outcomes.
- Further understanding of underlying mechanisms may refine therapeutic approaches.
Related Concept Videos
01:29Hepatic Encephalopathy
DefinitionHepatic encephalopathy is a reversible neurologic syndrome that results from advanced liver dysfunction or portosystemic shunting. It leads to disturbances in cognition, behavior, and motor function due to the brain’s exposure to gut-derived toxins that the liver fails to detoxify.EtiologyThis condition develops either in the setting of acute fulminant hepatitis or progressively during chronic liver disease, such as cirrhosis and portal hypertension. Portosystemic shunting—including...
01:19Encephalitis l: Introduction
Encephalitis is inflammation of the brain parenchyma, most often due to infections or autoimmune processes. It presents with neuropsychiatric features such as fever, altered mental status, behavioral changes, cognitive dysfunction, seizures, focal deficits, and sometimes autonomic instability. In some cases, the meninges are also involved, resulting in meningoencephalitis.Infectious CausesInfectious encephalitis is most commonly viral but can also result from bacterial, fungal, or parasitic...
01:23Urea Cycle
The urea cycle describes how liver cells convert ammonia to urea. Ammonia is a toxic waste product of protein catabolism. Land animals must convert ammonia into the less toxic urea which can be safely eliminated by the kidneys through urine. Marine animals excrete ammonia directly, and the surrounding water dilutes the ammonia to safe levels.
01:26Encephalitis ll: Pathophysiology
Encephalitis is inflammation of the brain parenchyma caused by direct viral invasion or immune-mediated mechanisms triggered by infections or tumors. Both processes lead to neuronal injury, disrupted neurotransmission, and diverse neurological symptoms, often with overlapping clinical and pathological features.Autoimmune EncephalitisIn autoimmune encephalitis, antibodies target neuronal antigens on cell surfaces, synapses, or within neurons. A key example is anti-NMDAR encephalitis, which can...
01:28Amebiasis
Entamoeba histolytica, a protozoan parasite, is responsible for intestinal and extraintestinal amebiasis. Though a significant proportion of infections remain asymptomatic, approximately 50 million individuals annually are estimated to present with clinical disease, resulting in up to 100,000 deaths globally. The disease burden is disproportionately high in regions with lower socioeconomic status, such as parts of India, Africa, Mexico, and Latin America.Etiology and TransmissionThe infective...
01:20Inborn Errors of Metabolism
Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...